The Braincoder project aims to develop a highly innovative new medical device designed to restore auditory perception in people with profound deafness (50 million people worldwide, including 100,000 with no therapeutic solution), without information loss, unlike current devices (cochlear implants or auditory brainstem implants). The project originates from the work of Brice Bathellier, Research Director at the Institut de l’Audition / Institut Pasteur, within a joint CNRS/INSERM research unit. The medical device is a brain implant based on artificial intelligence technology capable of translating sounds into electrical signals and directly stimulating the auditory cortex. Our implant converts sound information into the language of the brain. In June 2025, the project was awarded the Béatrice Denys Prize for its strong scientific, clinical, and entrepreneurial potential. The project is also supported by the Brain Institute (ICM) through its Neural program. The creation of a startup is planned by the end of 2026.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category